Physician profile
Allison K Slice
NPI 1801869797
$4,742.82
in general payments reported to CMS, 2019-2025
41 companies · $1,229 in 2025
The $1,229 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $576 · 2022: $860 · 2023: $1,130 · 2024: $948 · 2025: $1,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,306.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,348.41 | 2021-2025 | |
| Novo Nordisk INC | $573.46 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $303.43 | 2021-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $273.66 | 2021-2025 | Mounjaro, Zepbound, Kisunla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $266.45 | 2021-2025 | Xifaxan, Trulance |
| Pfizer INC. | $227.80 | 2021-2025 | |
| Amgen INC. | $140.19 | 2021-2025 | Repatha, Otezla, Repatha |
| Corcept Therapeutics | $138.19 | 2025 | Korlym |
| Abbott Laboratories | $124.33 | 2021-2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $107.41 | 2021-2025 | Gvoke Hypopen |
| Sunovion Pharmaceuticals INC. | $102.17 | 2021-2022 | |
| Eisai INC. | $85.94 | 2021-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $79.56 | 2022-2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $71.75 | 2024-2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $69.25 | 2023-2025 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Slice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.